Contract facts
FederalNo full NAICS 541712 intel page yet. Browse NAICS intelligence
CLINICAL TRIALS is a federal award for National Institutes Of Health Nichd held by Duke University. Estimated value $5.4M ($-550,678.7 obligated). Current period of performance ends Jul 21, 2022. Place of performance: DURHAM NC.
Recompete timing
PublicCurrent PoP ended Jul 21, 2022 (1492 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordDuke University — $183.3M obligated across 191 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract HHSN27500051?
HHSN27500051 (Clinical TRIALS) is a National Institutes Of Health Nichd award with a potential value of $5.4M, currently held by Duke University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded HHSN27500051?
National Institutes Of Health Nichd awarded HHSN27500051 to Duke University (potential $5.4M).
Who is the incumbent on HHSN27500051?
Duke University is the incumbent with $183.3M across 191 related awards in SCOUT’s public footprint. The current period of performance ends Jul 21, 2022.
When does Duke University’s HHSN27500051 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 21, 2022. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.